WallStSmart
SHC

Sotera Health Co

NASDAQ: SHC · HEALTHCARE · DIAGNOSTICS & RESEARCH

$15.45
-0.58% today

Updated 2026-04-29

Market cap
$4.41B
P/E ratio
57.22
P/S ratio
3.79x
EPS (TTM)
$0.27
Dividend yield
52W range
$11 – $20
Volume
2.9M

Sotera Health Co (SHC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+15.0%
Last 4 quarters
Revenue YoY growth
+4.6%
Most recent quarter
EPS YoY growth
+23.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+25.3%
2025-08-08
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-24$0.26+7.3%$17.49$16.16-7.6%
2025-11-04$0.26+20.0%$16.61$15.81-4.8%
2025-08-08$0.20+17.6%$11.22$14.06+25.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.24$0.26+7.3%$303.44M+4.6%
2025-09-30$0.22$0.26+20.0%$311.31M+9.1%
2025-06-30$0.17$0.20+17.6%$294.34M+6.4%
2025-03-31$0.12$0.14+14.9%$254.52M+2.6%
2024-12-31$0.20$0.21+4.0%$290.20M-6.5%
2024-09-30$0.18$0.17-5.6%$285.47M+8.5%
2024-06-30$0.16$0.19+18.8%$276.59M+8.3%
2024-03-31$0.13$0.13+0.0%$248.18M
2023-12-31$0.26$0.26+0.0%$310.24M
2023-09-30$0.20$0.21+5.0%$263.18M
2023-06-30$0.18$0.21+16.7%$255.28M

Frequently asked questions

Has Sotera Health Co beaten earnings estimates?
Sotera Health Co has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +15.0% over the last 4 quarters.
How does SHC stock react to earnings?
SHC stock has moved an average of +4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Sotera Health Co's revenue growth rate?
Sotera Health Co reported year-over-year revenue growth of +4.6% in its most recent quarter, with EPS growing +23.8% year-over-year.